BioSpace News Archive

Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2019.

Specially engineered for Align Technology’s Invisalign® system, SmartTrack material straightens teeth with more predictability

Beyond Air, Inc. announced the successful completion of a 30-day rat toxicology study and provided an update on its 12-week toxicology studies in both rats and dogs.

RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), today announced its support of a number of prevention and awareness initiatives for Stomach Cancer Awareness Month, including its sponsorship of the No Stomach For Cancer’s (NSFC) Spotlight on Stomach Cancer Symposium

Hollister Incorporated, an independent, employee-owned company that develops, manufactures, and markets healthcare products worldwide is pleased to announce a $100,000 commitment to support University of Alabama Adapted Athletics.

Quantum Leap Healthcare Collaborative is pleased to announce that co-founder Dr. Laura Esserman will be among the speakers of the first-ever TIME 100 Health Summit, which will convene individuals from the TIME 100 community and prominent figures in healthcare to highlight essential perspectives on health and wellness, and to encourage cross-disciplinary collaboration toward a better, healthier world.

PetaGene announced today that their PetaSuite software has been selected to compress the genomics data sets for AstraZeneca’s Centre for Genomics Research (CGR).

Hospitals and health systems looking to establish brand dominance, competitive distinction and clinical excellence in diabetes care can turn to a team of experts at Glytec dedicated to helping facilitate full adoption of best practices.

The Center for Innovative GYN Care® (CIGC®) co-founders, Dr. Paul MacKoul and Dr. Natalya Danilyants announced today that a Company abstract has been accepted for a presentation at this year’s ASRM Scientific Congress and Expo.

Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced that Steven Gygi, Ph.D., will join its scientific advisory board.